People with sarcoidosis may have additional risk factors for reduced bone strength, including inflammation, limited activity, low vitamin D, age or corticosteroid treatment. Bone health can be assessed with clinical review and, when appropriate, bone-density testing. Weight-bearing activity, adequate nutrition and prescribed treatment may help. Discuss fracture prevention with your clinician, particularly before or during long-term corticosteroid therapy.
Study reports frequent spinal fractures in people with sarcoidosis
Chest X-rays and lung-function tests may help assess fracture risk.
Bone fractures, particularly those affecting the spine, were a common complication in a study of almost 400 people with sarcoidosis.
The data linked sarcoidosis-related lung involvement and reduced lung function with a higher risk of major bone fractures.
The researchers suggested that chest X-rays used to assess lung involvement, together with lung-function tests, could help define fracture risk in people with sarcoidosis.
The analysis was published as “Osteoporosis and major fragility fractures (MOF) in sarcoidosis patients: association with disease severity” in Aging Clinical and Experimental Research.
Osteoporosis, sarcoidosis and corticosteroid treatment
In sarcoidosis, clusters of abnormally activated immune cells called granulomas form in tissues and organs, including the lungs, liver, heart, intestines, muscles and brain. Over time, these granulomas can harden and cause lasting tissue damage.
Chronic inflammation associated with sarcoidosis can also affect bone. The article describes corticosteroids, which are used to control abnormal immune responses, as making bones more fragile and prone to fracture, a condition called osteoporosis.
Researchers at the University of Siena in Italy noted that reports of bone mineral loss or major osteoporotic fractures (MOF) in sarcoidosis were scarce and had produced conflicting findings.
To investigate these uncertainties, the researchers assessed fracture history and bone mineral density, a measure of bone strength, in 382 patients with sarcoidosis. They also examined factors that might contribute to fractures.
The researchers stated that, to their knowledge, this was the first study to evaluate the prevalence and clinical impact of MOF in a large cohort of patients with sarcoidosis.
The single-centre study included 229 women and 153 men, with a mean age of 55.8 years.
Age is a recognised risk factor for osteoporosis. Patients with major fractures were older than those without fractures: an average of 60.7 versus 54.3 years.
Spinal fractures were the most common fractures in the study
A total of 90 patients (23.6%) had a major osteoporotic fracture, and 52 reported more than one fracture. Most fractures, 81 in total, affected the bones of the spine, or vertebrae. Far fewer affected the limbs: seven involved the wrist, five the upper-arm bone (humerus) and four the thigh bone (femur).
The researchers highlighted that roughly one quarter of the study participants had a major fracture and more than one fifth had at least one vertebral fracture.
Bone density was assessed with the non-invasive technique of dual-energy X-ray absorptiometry. It was significantly lower in patients with fractures than in those without, particularly at the femoral neck, at the top of the thigh bone, and at the total hip. Bone density in the lower, or lumbar, spine was also lower, but that difference was not statistically significant.
After adjustment for age and body mass index (BMI), a measure of weight relative to height, lower bone density at the femoral neck, total hip and lumbar spine correlated significantly with lower diffusing capacity for carbon monoxide (DLCO). The article describes DLCO as estimating the lungs’ ability to transfer oxygen from the air into the bloodstream.
The team then examined chest X-rays. Major fractures were more prevalent in patients with sarcoidosis-related lung involvement than in those without it: 28.3% versus 19.2%.
A further statistical analysis accounted for factors that could influence the results, including sex, BMI, blood vitamin D, lung function and involvement, sarcoidosis treatment and corticosteroid dose.
Lower DLCO values and a higher BMI were associated with a higher risk of osteoporosis. Greater lung involvement, lower total-hip bone density and less sarcoidosis treatment were associated with more major osteoporotic fractures.
The authors concluded that major osteoporotic fractures, particularly vertebral fractures, were a common and important complication in their large cohort of patients with moderate or severe sarcoidosis.
Source: Sarcoidosis News: Spinal bone fractures common in sarcoidosis patients, study finds